Collateral for a security interest recorded Oct 20, 2025 (Biopharma Credit PLC).
Term ends Jul 22, 2043 · High confidence
20-year base term ends Aug 10, 2040
Held by Valneva SE
Filed Feb 4, 2022 as application 17/632,946 · Granted Apr 21, 2026
Base term plus 1079 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2020
2043
Clock starts
Aug 10, 2020
Aug 10, 2020
Term ends
Jul 22, 2043
Jul 22, 2043
Granted
Apr 21, 2026
Apr 21, 2026
base term
patent term adjustment
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,079
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 12,605,436.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 1079 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Aug 10, 2020, when application PCT/EP2020/072436, the earliest non-provisional in its chain, was filed (this one was filed Feb 4, 2022) | Aug 10, 2040 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1079 days, USPTO patent term adjustment record | Jul 25, 2043 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 12,605,436) | capped to Jul 22, 2043 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jul 22, 2043 | High confidence |
Partial family
| Application PCT/EP2020/072436 | PCT application no patent term | no patent term |
| US 12,605,437 | this patent Jul 2043 | Jul 2043 |
Partial: 1 of the 2 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 31, 2022 Reel 60951, frame 79 | Wressnigg, Nina; Hochreiter, Romana | Valneva SE | Assignment of Assignor's Interest |
| Jan 19, 2024 Reel 66182, frame 174 | Valneva SE; Valneva Austria GmbH; Valneva USA, Inc.; Valneva Sweden AB | Wilmington Trust, National Association | Security Interest |
| Oct 20, 2025 Reel 73164, frame 32 | Valneva Austria GmbH; Valneva SE; Valneva Sweden AB | Biopharma Credit PLC, as Collateral Agent | Patent Security Agreement |
| Nov 10, 2025 Reel 73516, frame 522 | Wilmington Trust, National Association, as Administrative Agent | Valneva Austria GmbH; Valneva SE; Valneva USA, Inc. | Release of Security Interest |
| Nov 10, 2025 reel/frame not recorded | Wilmington Trust, National Association, as Administrative Agent | Valneva Austria GmbH | Release of Security Interest |
| Nov 10, 2025 reel/frame not recorded | Wilmington Trust, National Association, as Administrative Agent | Valneva SE | Release of Security Interest |
| Nov 10, 2025 reel/frame not recorded | Wilmington Trust, National Association, as Administrative Agent | Valneva USA, Inc. | Release of Security Interest |
| Mar 31, 2026 Reel 75335, frame 609 | Valneva Austria GmbH; Valneva SE; Valneva Sweden AB | Biopharma Credit PLC, as Collateral Agent | Amended and Restated Patent Security Agreement |
| Jun 4, 2026 Reel 75803, frame 558 | Valneva Austria GmbH; Valneva SE; Valneva Sweden AB | Biopharma Credit PLC, as Collateral Agent | Amended and Restated Patent Security Agreement |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jul 2043
Term ends Jul 22, 2043. Maintenance fees still fall due before then
Note
The 1079 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 12,605,436.
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.